Leo Wealth »

Sensei Biotherapeutics shares owned by Leo Wealth

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Leo Wealth from 13F filings

Historical chart of Leo Wealth investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Leo Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Leo Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $10k 15k 0.69

More positions owned by Leo Wealth

Johnson & Johnson (JNJ)
Vanguard World Esg Us Stk Etf (ESGV)
Affirm Hldgs Com Cl A (AFRM)
Vanguard World Esg Intl Stk Etf (VSGX)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Apple (AAPL)
Amazon (AMZN)
Ishares U S Etf Tr Int Rt Hdg C B (LQDH)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Wisdomtree Tr Floatng Rat Trea (USFR)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Leo Wealth

Top funds holding Sensei Biotherapeutics

Newtyn Management
Vanguard Group
Duquesne Family Office
Bank of America Corporation
Millennium Management
Citadel Advisors
Two Sigma Advisers
Leo Wealth
Raymond James & Associates
Deuterium Capital Management
Two Sigma Investments
Banque Cantonale Vaudoise
Jpmorgan Chase & Co
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Sensei Biotherapeutics